• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ZTS:US

37.2500 USD 0.5500 1.50%

As of 15:45:24 ET on 09/19/2014.

Snapshot for Zoetis Inc (ZTS)

Open: 36.8400 Day's Range: 36.8400 - 37.3100 Volume: 4,536,855
Previous Close: 36.7000 52wk Range: 28.1350 - 37.3100 1-Yr Rtn: +15.63%

Stock Chart for ZTS

No chart data available.
  • ZTS:US 37.2500
  • 1D
  • 1M
  • 1Y
36.7000
Interactive ZTS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZTS

Current P/E Ratio (ttm) 27.1818
Estimated P/E(12/2014) 24.3934
Relative P/E vs. SPX 1.4981
Earnings Per Share (USD) (ttm) 1.3686
Est. EPS (USD) (12/2014) 1.5250
Est. PEG Ratio 2.0957
Market Cap (M USD) 18,644.39
Shares Outstanding (M) 501.19
30 Day Average Volume 2,585,803
Price/Book (mrq) 14.8065
Price/Sale (ttm) 4.0408
Dividend Indicated Gross Yield 0.77%
Cash Dividend (USD) 0.0720
Dividend Ex-Date 08/18/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZTS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZTS

Zoetis Inc discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Companies products are sold in North America, Europe, Africa, Asia, Australia and Latin America.

Juan Ramon AlaixChief Executive OfficerGlenn DavidSenior VP:Finance Operations
Kristin C PeckExec VP/Group PresidentPaul S HerendeenExec VP/CFO
More Company Profile & Key Executives for ZTS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil